Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick Raal

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
BMJ (Clinical Research Ed.)|November 23, 2019
A pain in the neckFarzahna Mohamed, Frederick Raal
Current Opinion in Lipidology|April 26, 2023
Lipid metabolismFrederick Raal, Marina Cuchel
Annual Review of Medicine|January 16, 2014
Reduction of low-density lipoprotein cholesterol by monoclonal antibody inhibition of PCSK9Evan A Stein, Frederick Raal
Cardiovascular Drugs and Therapy|February 11, 2016
Future Directions to Establish Lipoprotein(a) as a Treatment for Atherosclerotic Cardiovascular DiseaseEvan A Stein, Frederick Raal
Journal of Clinical Lipidology|September 24, 2022
Monkeypox is a global public health emergency: The role of repurposing cholesterol lowering drugs not to be forgottenAlpo Vuorio, Frederick Raal, Petri T Kovanen
Reviews in Cardiovascular Medicine|July 30, 2024
Familial Hypercholesterolemia Patients with COVID-19-Effective Cholesterol-Lowering Therapy is Urgent both during and after InfectionAlpo Vuorio, Frederick Raal, Petri T Kovanen
American Journal of Preventive Cardiology|July 27, 2021
Patients with familial hypercholesterolemia and COVID-19: Efficient and ongoing cholesterol lowering is paramount for the prevention of acute myocardial infarctionPetri T Kovanen, Frederick Raal, Alpo Vuorio
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 5, 2022
Drug-drug interaction with oral antivirals for the early treatment of COVID-19Alpo Vuorio, Frederick Raal, Petri T Kovanen
Future Virology|August 8, 2022
Cholesterol-lowering drugs for high-risk hypercholesterolemia patients with COVID-19 while on Paxlovid™ therapyAlpo Vuorio, Petri T Kovanen, Frederick Raal
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2022
Statin Needs to be Continued During Paxlovid Therapy in COVID-19Alpo Vuorio, Petri T Kovanen, Frederick Raal
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
BMJ (Clinical Research Ed.)|November 23, 2019
A pain in the neckFarzahna Mohamed, Frederick Raal
Current Opinion in Lipidology|April 26, 2023
Lipid metabolismFrederick Raal, Marina Cuchel
Annual Review of Medicine|January 16, 2014
Reduction of low-density lipoprotein cholesterol by monoclonal antibody inhibition of PCSK9Evan A Stein, Frederick Raal
Cardiovascular Drugs and Therapy|February 11, 2016
Future Directions to Establish Lipoprotein(a) as a Treatment for Atherosclerotic Cardiovascular DiseaseEvan A Stein, Frederick Raal
Journal of Clinical Lipidology|September 24, 2022
Monkeypox is a global public health emergency: The role of repurposing cholesterol lowering drugs not to be forgottenAlpo Vuorio, Frederick Raal, Petri T Kovanen
Reviews in Cardiovascular Medicine|July 30, 2024
Familial Hypercholesterolemia Patients with COVID-19-Effective Cholesterol-Lowering Therapy is Urgent both during and after InfectionAlpo Vuorio, Frederick Raal, Petri T Kovanen
American Journal of Preventive Cardiology|July 27, 2021
Patients with familial hypercholesterolemia and COVID-19: Efficient and ongoing cholesterol lowering is paramount for the prevention of acute myocardial infarctionPetri T Kovanen, Frederick Raal, Alpo Vuorio
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 5, 2022
Drug-drug interaction with oral antivirals for the early treatment of COVID-19Alpo Vuorio, Frederick Raal, Petri T Kovanen
Future Virology|August 8, 2022
Cholesterol-lowering drugs for high-risk hypercholesterolemia patients with COVID-19 while on Paxlovid™ therapyAlpo Vuorio, Petri T Kovanen, Frederick Raal
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2022
Statin Needs to be Continued During Paxlovid Therapy in COVID-19Alpo Vuorio, Petri T Kovanen, Frederick Raal
Pageof 5